Akero Therapeutics Inc buy Citigroup Inc.
Start price
28.01.25
/
50%
€53.14
Target price
28.01.26
€76.71
Performance (%)
-11.61%
End price
29.01.26
-
Summary
This prediction is currently being closed. The prediction for Akero Therapeutics Inc disappoints with a performance of -11.61%. Citigroup_Inc_ has a follow-up prediction for Akero Therapeutics Inc where he still thinks Akero Therapeutics Inc is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | - |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% |
Comments by Citigroup_Inc_ for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Citigroup Inc. from $65.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€35.77
13.05.25
13.05.25
€70.22
13.05.26
13.05.26
31.31%
08.12.25
08.12.25
Stopped prediction by Citigroup_Inc_ for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€27.54
18.11.24
18.11.24
€61.49
18.11.25
18.11.25
69.39%
19.11.25
19.11.25